High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis
NCT ID: NCT03015051
Last Updated: 2020-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
30 participants
INTERVENTIONAL
2017-01-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to evaluate in a large number of cases the effectiveness of treatment with high flow versus standard treatment, in children with bronchiolitis referred to a Pediatric Emergency Department.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of High-flow Oxygen Therapy Against Standard Therapy in Bronchiolitis
NCT01498094
High Flow in Infants With Bronchiolitis
NCT02913040
High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis
NCT02856165
Nasal Irrigation in Infants With Bronchiolitis.
NCT02162745
High Flow Nasal Cannula in Children With Status Asthmaticus
NCT03157102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High flow
High flow (2 L/kg/min) nasal cannula oxygen therapy
Oxygen
Low flow
Low flow (max 3 L/min) oxygen therapy
Oxygen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxygen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>28 days and \<6 months
* Oxygen saturation (SaO2) \<92%
* respiratory rate \>60 breaths/min
* dyspnea with respiratory distress assessment instrument (RDAI) score ≥8
* daily milk or food intake less than 2/3 than normally assumed
Exclusion Criteria
* respiratory diseases (i.e. bronchopulmonary dysplasia)
* heart diseases
* preterm birth (before 36 weeks of gestational age)
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Burlo Garofolo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luca Ronfani
Head of Clinical Epidemiology and Public Health Research Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Egidio Barbi, MD
Role: STUDY_CHAIR
IRCCS Burlo Garofolo, Trieste, Italy
Stefania Norbedo, MD
Role: STUDY_DIRECTOR
IRCCS Burlo Garofolo, Trieste, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale Maggiore
Bologna, Emilia-Romagna, Italy
Ospedale Morgagni-Pierantoni
Forlì, Emilia-Romagna, Italy
Ospedale Ravenna AUSL Romagna
Ravenna, Emilia-Romagna, Italy
Ospedale Santa Maria degli Angeli
Pordenone, Friuli Venezia Giulia, Italy
Pediatric Emergency Department, IRCCS Burlo Garofolo
Trieste, Friuli Venezia Giulia, Italy
Ospedale Pediatrico IRCCS Bambino Gesú
Rome, Lazio, Italy
Istituto G. Gaslini
Genoa, Liguria, Italy
Fondazione MBBM c/o Ospedale San Gerardo
Monza, Lombardy, Italy
Ospedale A. Cardarelli
Campobasso, Molise, Italy
Ospedale Infantile Regina Margherita
Turin, Piedmont, Italy
Ospedale Castelli
Verbania, Piedmont, Italy
Ospedale Giovanni Paolo II
Olbia, Sardinia, Italy
Ospedale Provinciale di Macerata
Macerata, The Marches, Italy
Ospedale Principe di Piemonte Area Vasta 2
Senigallia, The Marches, Italy
Azienda Ospedaliera di Padova
Padua, Veneto, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
High flow RCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.